enVVeno Medical Corporation - Common Stock — Cash Flow (NASDAQ:NVNO) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -7.68 M-11.85 M-15.62 M-18.86 M-16.84 M-15.57 M -14.79 M Cash from investing activities -180.29 K-367.89 K-34.55 M-7.87 M1.33 M15.86 M 13.43 M Cash from financing activities 15.07 M57.61 M025.79 M13.64 M1.02 M — Free cash flow -7.68 M-11.85 M-15.62 M-18.86 M-16.84 M-15.57 M -14.79 M

News

enVVeno Medical regains Nasdaq compliance, reports $28 million cash

enVVeno Medical announces 1-for-35 reverse stock split

enVVeno Medical updates bylaws to revise stockholder quorum requirement

enVVeno Medical stock plunges after FDA upholds rejection of VenoValve

Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher - Amaze Holdings (AMEX:AMZE), Cidara Therapeutics (NASDAQ:CDTX)

Nasdaq Dips Over 300 Points; Applied Materials Posts Upbeat Q4 Earnings - Applied Mat (NASDAQ:AMAT), Amaze Holdings (AMEX:AMZE)

Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Binah Capital Group (NASDAQ:BCG), Aspire Biopharma Hldgs (NASDAQ:ASBP)

FDA rejects enVVeno Medical’s appeal for VenoValve approval

EnVVeno Medical receives Nasdaq notice for minimum bid price non-compliance

enVVeno Medical to appeal FDA’s not-approvable letter for VenoValve

NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve

Nasdaq Down 1%; Lowe's Posts Upbeat Earnings - Calidi Biotherapeutics (AMEX:CLDI), Guess (NYSE:GES)